Prophylactic and therapeutic efficacy of Acinetobacter phage RMA1 against carbapenem-resistant Acinetobacter baumannii with no cytotoxicity to human skin cells | Synapse
March 3, 2026Open Access
Prophylactic and therapeutic efficacy of Acinetobacter phage RMA1 against carbapenem-resistant Acinetobacter baumannii with no cytotoxicity to human skin cells
Key Points
Acinetobacter phage RM_A1 shows therapeutic efficacy against carbapenem-resistant Acinetobacter baumannii infections, and it does not harm human skin cells.
The study reports no cytotoxicity observed in human skin cells during the treatment with the phage RM_A1.
Assessment using in vitro methods confirmed the phage's effectiveness without damaging healthy human tissue.
This highlights the potential of bacteriophages as a novel approach to combat antibiotic-resistant infections without adverse effects.